Event Date: Feb 21, 2024

Recording | Related Resources

Cognitive disorders are frequently accompanied by non-cognitive symptoms such as agitation and apathy. These symptoms have an additional negative impact on quality of life and are associated with disease progression.
This webinar will highlight non-pharmacologic interventions and medications that have been evaluated, and highlight those with evidence to show that they may alleviate symptoms.
This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium on Neurodegeneration in Aging (CCNA).


LANCTOT_DrKrista_220304_004.jpgKrista L. Lanctôt, PhD, Bernick Chair in Geriatric Psychopharmacology; Senior Scientist, Sunnybrook Research Institute; Professor of Psychiatry and Pharmacology, Vice Chair, Basic and Clinical Sciences, Department of Psychiatry, University of Toronto
Dr. Krista L. Lanctôt has a PhD in Clinical Pharmacology from the University of Toronto, and holds the Bernick Chair in Geriatric Psychopharmacology. She is currently a Senior Scientist in Geriatric Psychiatry and in the Hurvitz Brain Sciences Program at Sunnybrook Research Institute, Research Co-Director in the Department of Psychiatry at Sunnybrook Health Sciences Centre and the Head of Neuropsychopharmacology Research. She is also a Professor of Psychiatry and Pharmacology/Toxicology, and Vice Chair of Basic and Clinical Sciences in the Department of Psychiatry at the University of Toronto, Toronto, Ontario, Canada. 
Dr. Lanctôt is an active researcher with more than 390 published papers, and Editor of the 2021 book “Apathy: Clinical and Neuroscientific Perspectives from Neurology and Psychiatry”.  Her group’s research has focused on optimizing the treatment of cognition and neuropsychiatric symptoms associated with dementia and in predementia states.